aluates Reports

$ 0.0

Automative

Global Breast Cancer Recurrence Score Test Market Research Report 2025

Published Date: July 2025

Report Code: QYRE-Auto-0G6168

Global Breast Cancer Recurrence Score Test Market Insights Forecast to 2028

BUY CHAPTERS

Global Breast Cancer Recurrence Score Test Market Research Report 2025

Code: QYRE-Auto-0G6168

Report

July 2025

Pages:76

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Roche Diagnostics

Braster

Bremed

Forward Science Technologies

Guided Therapeutics

Varian Medical Systems

LED Dental

PWB Health

Zilico Medical Diagnostics

Breast Cancer Recurrence Score Test Market

The global market for Breast Cancer Recurrence Score Test was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

The breast cancer recurrence score test is a genomic test that extracts breast cancer tissue during surgery to check the activity of certain genes related to breast cancer, which is very helpful for the treatment of breast cancer. In addition, the breast cancer recurrence score test can also estimate the risk of early breast cancer.

North American market for Breast Cancer Recurrence Score Test is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Breast Cancer Recurrence Score Test is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Breast Cancer Recurrence Score Test in Hospitals is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Breast Cancer Recurrence Score Test include Roche Diagnostics, Braster, Bremed, Forward Science Technologies, Guided Therapeutics, Varian Medical Systems, LED Dental, PWB Health, Zilico Medical Diagnostics, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Breast Cancer Recurrence Score Test, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Breast Cancer Recurrence Score Test.

The Breast Cancer Recurrence Score Test market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Breast Cancer Recurrence Score Test market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Breast Cancer Recurrence Score Test companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Breast Cancer Recurrence Score Test Market Report

Report Metric	Details
Report Name	Breast Cancer Recurrence Score Test Market
Segment by Type	Stage I Invasive Breast Cancer Stage II Invasive Breast Cancer Estrogen Receptor-positive Cancer Lymph Node-negative Breast Cancer
Segment by Application	Hospitals Speciality Cancer Centers Advanced Diagnostic Centers Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Roche Diagnostics, Braster, Bremed, Forward Science Technologies, Guided Therapeutics, Varian Medical Systems, LED Dental, PWB Health, Zilico Medical Diagnostics
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Breast Cancer Recurrence Score Test company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Breast Cancer Recurrence Score Test Market report?

Ans: The main players in the Breast Cancer Recurrence Score Test Market are Roche Diagnostics, Braster, Bremed, Forward Science Technologies, Guided Therapeutics, Varian Medical Systems, LED Dental, PWB Health, Zilico Medical Diagnostics

What are the Application segmentation covered in the Breast Cancer Recurrence Score Test Market report?

Ans: The Applications covered in the Breast Cancer Recurrence Score Test Market report are Hospitals, Speciality Cancer Centers, Advanced Diagnostic Centers, Others

What are the Type segmentation covered in the Breast Cancer Recurrence Score Test Market report?

Ans: The Types covered in the Breast Cancer Recurrence Score Test Market report are Stage I Invasive Breast Cancer, Stage II Invasive Breast Cancer, Estrogen Receptor-positive Cancer, Lymph Node-negative Breast Cancer

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Breast Cancer Recurrence Score Test Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Stage I Invasive Breast Cancer

1.2.3 Stage II Invasive Breast Cancer

1.2.4 Estrogen Receptor-positive Cancer

1.2.5 Lymph Node-negative Breast Cancer

1.3 Market by Application

1.3.1 Global Breast Cancer Recurrence Score Test Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospitals

1.3.3 Speciality Cancer Centers

1.3.4 Advanced Diagnostic Centers

1.3.5 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Breast Cancer Recurrence Score Test Market Perspective (2020-2031)

2.2 Global Breast Cancer Recurrence Score Test Growth Trends by Region

2.2.1 Global Breast Cancer Recurrence Score Test Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Breast Cancer Recurrence Score Test Historic Market Size by Region (2020-2025)

2.2.3 Breast Cancer Recurrence Score Test Forecasted Market Size by Region (2026-2031)

2.3 Breast Cancer Recurrence Score Test Market Dynamics

2.3.1 Breast Cancer Recurrence Score Test Industry Trends

2.3.2 Breast Cancer Recurrence Score Test Market Drivers

2.3.3 Breast Cancer Recurrence Score Test Market Challenges

2.3.4 Breast Cancer Recurrence Score Test Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Breast Cancer Recurrence Score Test Players by Revenue

3.1.1 Global Top Breast Cancer Recurrence Score Test Players by Revenue (2020-2025)

3.1.2 Global Breast Cancer Recurrence Score Test Revenue Market Share by Players (2020-2025)

3.2 Global Breast Cancer Recurrence Score Test Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Breast Cancer Recurrence Score Test Revenue

3.4 Global Breast Cancer Recurrence Score Test Market Concentration Ratio

3.4.1 Global Breast Cancer Recurrence Score Test Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Breast Cancer Recurrence Score Test Revenue in 2024

3.5 Global Key Players of Breast Cancer Recurrence Score Test Head office and Area Served

3.6 Global Key Players of Breast Cancer Recurrence Score Test, Product and Application

3.7 Global Key Players of Breast Cancer Recurrence Score Test, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Breast Cancer Recurrence Score Test Breakdown Data by Type

4.1 Global Breast Cancer Recurrence Score Test Historic Market Size by Type (2020-2025)

4.2 Global Breast Cancer Recurrence Score Test Forecasted Market Size by Type (2026-2031)

5 Breast Cancer Recurrence Score Test Breakdown Data by Application

5.1 Global Breast Cancer Recurrence Score Test Historic Market Size by Application (2020-2025)

5.2 Global Breast Cancer Recurrence Score Test Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Breast Cancer Recurrence Score Test Market Size (2020-2031)

6.2 North America Breast Cancer Recurrence Score Test Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Breast Cancer Recurrence Score Test Market Size by Country (2020-2025)

6.4 North America Breast Cancer Recurrence Score Test Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Breast Cancer Recurrence Score Test Market Size (2020-2031)

7.2 Europe Breast Cancer Recurrence Score Test Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Breast Cancer Recurrence Score Test Market Size by Country (2020-2025)

7.4 Europe Breast Cancer Recurrence Score Test Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Breast Cancer Recurrence Score Test Market Size (2020-2031)

8.2 Asia-Pacific Breast Cancer Recurrence Score Test Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Breast Cancer Recurrence Score Test Market Size by Region (2020-2025)

8.4 Asia-Pacific Breast Cancer Recurrence Score Test Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Breast Cancer Recurrence Score Test Market Size (2020-2031)

9.2 Latin America Breast Cancer Recurrence Score Test Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Breast Cancer Recurrence Score Test Market Size by Country (2020-2025)

9.4 Latin America Breast Cancer Recurrence Score Test Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Breast Cancer Recurrence Score Test Market Size (2020-2031)

10.2 Middle East & Africa Breast Cancer Recurrence Score Test Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Breast Cancer Recurrence Score Test Market Size by Country (2020-2025)

10.4 Middle East & Africa Breast Cancer Recurrence Score Test Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Roche Diagnostics

11.1.1 Roche Diagnostics Company Details

11.1.2 Roche Diagnostics Business Overview

11.1.3 Roche Diagnostics Breast Cancer Recurrence Score Test Introduction

11.1.4 Roche Diagnostics Revenue in Breast Cancer Recurrence Score Test Business (2020-2025)

11.1.5 Roche Diagnostics Recent Development

11.2 Braster

11.2.1 Braster Company Details

11.2.2 Braster Business Overview

11.2.3 Braster Breast Cancer Recurrence Score Test Introduction

11.2.4 Braster Revenue in Breast Cancer Recurrence Score Test Business (2020-2025)

11.2.5 Braster Recent Development

11.3 Bremed

11.3.1 Bremed Company Details

11.3.2 Bremed Business Overview

11.3.3 Bremed Breast Cancer Recurrence Score Test Introduction

11.3.4 Bremed Revenue in Breast Cancer Recurrence Score Test Business (2020-2025)

11.3.5 Bremed Recent Development

11.4 Forward Science Technologies

11.4.1 Forward Science Technologies Company Details

11.4.2 Forward Science Technologies Business Overview

11.4.3 Forward Science Technologies Breast Cancer Recurrence Score Test Introduction

11.4.4 Forward Science Technologies Revenue in Breast Cancer Recurrence Score Test Business (2020-2025)

11.4.5 Forward Science Technologies Recent Development

11.5 Guided Therapeutics

11.5.1 Guided Therapeutics Company Details

11.5.2 Guided Therapeutics Business Overview

11.5.3 Guided Therapeutics Breast Cancer Recurrence Score Test Introduction

11.5.4 Guided Therapeutics Revenue in Breast Cancer Recurrence Score Test Business (2020-2025)

11.5.5 Guided Therapeutics Recent Development

11.6 Varian Medical Systems

11.6.1 Varian Medical Systems Company Details

11.6.2 Varian Medical Systems Business Overview

11.6.3 Varian Medical Systems Breast Cancer Recurrence Score Test Introduction

11.6.4 Varian Medical Systems Revenue in Breast Cancer Recurrence Score Test Business (2020-2025)

11.6.5 Varian Medical Systems Recent Development

11.7 LED Dental

11.7.1 LED Dental Company Details

11.7.2 LED Dental Business Overview

11.7.3 LED Dental Breast Cancer Recurrence Score Test Introduction

11.7.4 LED Dental Revenue in Breast Cancer Recurrence Score Test Business (2020-2025)

11.7.5 LED Dental Recent Development

11.8 PWB Health

11.8.1 PWB Health Company Details

11.8.2 PWB Health Business Overview

11.8.3 PWB Health Breast Cancer Recurrence Score Test Introduction

11.8.4 PWB Health Revenue in Breast Cancer Recurrence Score Test Business (2020-2025)

11.8.5 PWB Health Recent Development

11.9 Zilico Medical Diagnostics

11.9.1 Zilico Medical Diagnostics Company Details

11.9.2 Zilico Medical Diagnostics Business Overview

11.9.3 Zilico Medical Diagnostics Breast Cancer Recurrence Score Test Introduction

11.9.4 Zilico Medical Diagnostics Revenue in Breast Cancer Recurrence Score Test Business (2020-2025)

11.9.5 Zilico Medical Diagnostics Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Roche Diagnostics

Braster

Bremed

Forward Science Technologies

Guided Therapeutics

Varian Medical Systems

LED Dental

PWB Health

Zilico Medical Diagnostics

List of Tables

Table 1. Global Breast Cancer Recurrence Score Test Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Stage I Invasive Breast Cancer

Table 3. Key Players of Stage II Invasive Breast Cancer

Table 4. Key Players of Estrogen Receptor-positive Cancer

Table 5. Key Players of Lymph Node-negative Breast Cancer

Table 6. Global Breast Cancer Recurrence Score Test Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Breast Cancer Recurrence Score Test Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Breast Cancer Recurrence Score Test Market Size by Region (2020-2025) & (US$ Million)

Table 9. Global Breast Cancer Recurrence Score Test Market Share by Region (2020-2025)

Table 10. Global Breast Cancer Recurrence Score Test Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 11. Global Breast Cancer Recurrence Score Test Market Share by Region (2026-2031)

Table 12. Breast Cancer Recurrence Score Test Market Trends

Table 13. Breast Cancer Recurrence Score Test Market Drivers

Table 14. Breast Cancer Recurrence Score Test Market Challenges

Table 15. Breast Cancer Recurrence Score Test Market Restraints

Table 16. Global Breast Cancer Recurrence Score Test Revenue by Players (2020-2025) & (US$ Million)

Table 17. Global Breast Cancer Recurrence Score Test Market Share by Players (2020-2025)

Table 18. Global Top Breast Cancer Recurrence Score Test Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Breast Cancer Recurrence Score Test as of 2024)

Table 19. Ranking of Global Top Breast Cancer Recurrence Score Test Companies by Revenue (US$ Million) in 2024

Table 20. Global 5 Largest Players Market Share by Breast Cancer Recurrence Score Test Revenue (CR5 and HHI) & (2020-2025)

Table 21. Global Key Players of Breast Cancer Recurrence Score Test, Headquarters and Area Served

Table 22. Global Key Players of Breast Cancer Recurrence Score Test, Product and Application

Table 23. Global Key Players of Breast Cancer Recurrence Score Test, Date of Enter into This Industry

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Breast Cancer Recurrence Score Test Market Size by Type (2020-2025) & (US$ Million)

Table 26. Global Breast Cancer Recurrence Score Test Revenue Market Share by Type (2020-2025)

Table 27. Global Breast Cancer Recurrence Score Test Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 28. Global Breast Cancer Recurrence Score Test Revenue Market Share by Type (2026-2031)

Table 29. Global Breast Cancer Recurrence Score Test Market Size by Application (2020-2025) & (US$ Million)

Table 30. Global Breast Cancer Recurrence Score Test Revenue Market Share by Application (2020-2025)

Table 31. Global Breast Cancer Recurrence Score Test Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 32. Global Breast Cancer Recurrence Score Test Revenue Market Share by Application (2026-2031)

Table 33. North America Breast Cancer Recurrence Score Test Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 34. North America Breast Cancer Recurrence Score Test Market Size by Country (2020-2025) & (US$ Million)

Table 35. North America Breast Cancer Recurrence Score Test Market Size by Country (2026-2031) & (US$ Million)

Table 36. Europe Breast Cancer Recurrence Score Test Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. Europe Breast Cancer Recurrence Score Test Market Size by Country (2020-2025) & (US$ Million)

Table 38. Europe Breast Cancer Recurrence Score Test Market Size by Country (2026-2031) & (US$ Million)

Table 39. Asia-Pacific Breast Cancer Recurrence Score Test Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 40. Asia-Pacific Breast Cancer Recurrence Score Test Market Size by Region (2020-2025) & (US$ Million)

Table 41. Asia-Pacific Breast Cancer Recurrence Score Test Market Size by Region (2026-2031) & (US$ Million)

Table 42. Latin America Breast Cancer Recurrence Score Test Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 43. Latin America Breast Cancer Recurrence Score Test Market Size by Country (2020-2025) & (US$ Million)

Table 44. Latin America Breast Cancer Recurrence Score Test Market Size by Country (2026-2031) & (US$ Million)

Table 45. Middle East & Africa Breast Cancer Recurrence Score Test Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Middle East & Africa Breast Cancer Recurrence Score Test Market Size by Country (2020-2025) & (US$ Million)

Table 47. Middle East & Africa Breast Cancer Recurrence Score Test Market Size by Country (2026-2031) & (US$ Million)

Table 48. Roche Diagnostics Company Details

Table 49. Roche Diagnostics Business Overview

Table 50. Roche Diagnostics Breast Cancer Recurrence Score Test Product

Table 51. Roche Diagnostics Revenue in Breast Cancer Recurrence Score Test Business (2020-2025) & (US$ Million)

Table 52. Roche Diagnostics Recent Development

Table 53. Braster Company Details

Table 54. Braster Business Overview

Table 55. Braster Breast Cancer Recurrence Score Test Product

Table 56. Braster Revenue in Breast Cancer Recurrence Score Test Business (2020-2025) & (US$ Million)

Table 57. Braster Recent Development

Table 58. Bremed Company Details

Table 59. Bremed Business Overview

Table 60. Bremed Breast Cancer Recurrence Score Test Product

Table 61. Bremed Revenue in Breast Cancer Recurrence Score Test Business (2020-2025) & (US$ Million)

Table 62. Bremed Recent Development

Table 63. Forward Science Technologies Company Details

Table 64. Forward Science Technologies Business Overview

Table 65. Forward Science Technologies Breast Cancer Recurrence Score Test Product

Table 66. Forward Science Technologies Revenue in Breast Cancer Recurrence Score Test Business (2020-2025) & (US$ Million)

Table 67. Forward Science Technologies Recent Development

Table 68. Guided Therapeutics Company Details

Table 69. Guided Therapeutics Business Overview

Table 70. Guided Therapeutics Breast Cancer Recurrence Score Test Product

Table 71. Guided Therapeutics Revenue in Breast Cancer Recurrence Score Test Business (2020-2025) & (US$ Million)

Table 72. Guided Therapeutics Recent Development

Table 73. Varian Medical Systems Company Details

Table 74. Varian Medical Systems Business Overview

Table 75. Varian Medical Systems Breast Cancer Recurrence Score Test Product

Table 76. Varian Medical Systems Revenue in Breast Cancer Recurrence Score Test Business (2020-2025) & (US$ Million)

Table 77. Varian Medical Systems Recent Development

Table 78. LED Dental Company Details

Table 79. LED Dental Business Overview

Table 80. LED Dental Breast Cancer Recurrence Score Test Product

Table 81. LED Dental Revenue in Breast Cancer Recurrence Score Test Business (2020-2025) & (US$ Million)

Table 82. LED Dental Recent Development

Table 83. PWB Health Company Details

Table 84. PWB Health Business Overview

Table 85. PWB Health Breast Cancer Recurrence Score Test Product

Table 86. PWB Health Revenue in Breast Cancer Recurrence Score Test Business (2020-2025) & (US$ Million)

Table 87. PWB Health Recent Development

Table 88. Zilico Medical Diagnostics Company Details

Table 89. Zilico Medical Diagnostics Business Overview

Table 90. Zilico Medical Diagnostics Breast Cancer Recurrence Score Test Product

Table 91. Zilico Medical Diagnostics Revenue in Breast Cancer Recurrence Score Test Business (2020-2025) & (US$ Million)

Table 92. Zilico Medical Diagnostics Recent Development

Table 93. Research Programs/Design for This Report

Table 94. Key Data Information from Secondary Sources

Table 95. Key Data Information from Primary Sources

Table 96. Authors List of This Report

List of Figures

Figure 1. Breast Cancer Recurrence Score Test Picture

Figure 2. Global Breast Cancer Recurrence Score Test Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Breast Cancer Recurrence Score Test Market Share by Type: 2024 VS 2031

Figure 4. Stage I Invasive Breast Cancer Features

Figure 5. Stage II Invasive Breast Cancer Features

Figure 6. Estrogen Receptor-positive Cancer Features

Figure 7. Lymph Node-negative Breast Cancer Features

Figure 8. Global Breast Cancer Recurrence Score Test Market Size by Application (2020-2031) & (US$ Million)

Figure 9. Global Breast Cancer Recurrence Score Test Market Share by Application: 2024 VS 2031

Figure 10. Hospitals Case Studies

Figure 11. Speciality Cancer Centers Case Studies

Figure 12. Advanced Diagnostic Centers Case Studies

Figure 13. Others Case Studies

Figure 14. Breast Cancer Recurrence Score Test Report Years Considered

Figure 15. Global Breast Cancer Recurrence Score Test Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 16. Global Breast Cancer Recurrence Score Test Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 17. Global Breast Cancer Recurrence Score Test Market Share by Region: 2024 VS 2031

Figure 18. Global Breast Cancer Recurrence Score Test Market Share by Players in 2024

Figure 19. Global Top Breast Cancer Recurrence Score Test Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Breast Cancer Recurrence Score Test as of 2024)

Figure 20. The Top 10 and 5 Players Market Share by Breast Cancer Recurrence Score Test Revenue in 2024

Figure 21. North America Breast Cancer Recurrence Score Test Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. North America Breast Cancer Recurrence Score Test Market Share by Country (2020-2031)

Figure 23. United States Breast Cancer Recurrence Score Test Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Canada Breast Cancer Recurrence Score Test Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Breast Cancer Recurrence Score Test Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Europe Breast Cancer Recurrence Score Test Market Share by Country (2020-2031)

Figure 27. Germany Breast Cancer Recurrence Score Test Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. France Breast Cancer Recurrence Score Test Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. U.K. Breast Cancer Recurrence Score Test Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Italy Breast Cancer Recurrence Score Test Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Russia Breast Cancer Recurrence Score Test Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Nordic Countries Breast Cancer Recurrence Score Test Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Breast Cancer Recurrence Score Test Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Asia-Pacific Breast Cancer Recurrence Score Test Market Share by Region (2020-2031)

Figure 35. China Breast Cancer Recurrence Score Test Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Japan Breast Cancer Recurrence Score Test Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. South Korea Breast Cancer Recurrence Score Test Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Southeast Asia Breast Cancer Recurrence Score Test Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. India Breast Cancer Recurrence Score Test Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Australia Breast Cancer Recurrence Score Test Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Breast Cancer Recurrence Score Test Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Latin America Breast Cancer Recurrence Score Test Market Share by Country (2020-2031)

Figure 43. Mexico Breast Cancer Recurrence Score Test Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Brazil Breast Cancer Recurrence Score Test Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Breast Cancer Recurrence Score Test Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Middle East & Africa Breast Cancer Recurrence Score Test Market Share by Country (2020-2031)

Figure 47. Turkey Breast Cancer Recurrence Score Test Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Saudi Arabia Breast Cancer Recurrence Score Test Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. UAE Breast Cancer Recurrence Score Test Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. Roche Diagnostics Revenue Growth Rate in Breast Cancer Recurrence Score Test Business (2020-2025)

Figure 51. Braster Revenue Growth Rate in Breast Cancer Recurrence Score Test Business (2020-2025)

Figure 52. Bremed Revenue Growth Rate in Breast Cancer Recurrence Score Test Business (2020-2025)

Figure 53. Forward Science Technologies Revenue Growth Rate in Breast Cancer Recurrence Score Test Business (2020-2025)

Figure 54. Guided Therapeutics Revenue Growth Rate in Breast Cancer Recurrence Score Test Business (2020-2025)

Figure 55. Varian Medical Systems Revenue Growth Rate in Breast Cancer Recurrence Score Test Business (2020-2025)

Figure 56. LED Dental Revenue Growth Rate in Breast Cancer Recurrence Score Test Business (2020-2025)

Figure 57. PWB Health Revenue Growth Rate in Breast Cancer Recurrence Score Test Business (2020-2025)

Figure 58. Zilico Medical Diagnostics Revenue Growth Rate in Breast Cancer Recurrence Score Test Business (2020-2025)

Figure 59. Bottom-up and Top-down Approaches for This Report

Figure 60. Data Triangulation

Figure 61. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Breast Cancer Testing Market Insights Forecast to 2030

Global Tumor NGS Genetic Testing Market Research Report 2024

Global Genomic Testing in Cancer Market Research Report 2024

Global Cancer Genomic Testing Market Research Report 2024

Global Pan cancer Genetic Testing Market Research Report 2025

Global Breast Cancer Predictive Genetic Testing Market Research Report 2024

Global Molecular Diagnostics Cancer Market Insights Forecast to 2030

Gene Expression Screening Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Precision Cancer Tests Market Research Report 2024

Global Breast Cancer Diagnostic and Drug Technologies Market Insights Forecast to 2030

Global Tumor Genomics Market Research Report 2024

Global Colorectal Cancer Molecular Diagnostics Market Research Report 2024

Cancer Microbiome Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global HER2 Tumor Marker Testing Market Research Report 2024

Global Rapid Cancer Tests Market Insights Forecast to 2030

Global Tissue Testing Market Research Report 2024

Global Gene Panel Market Research Report 2024

Global Clinical Biomarker Testing Market Research Report 2024

Global Breast Cancer Molecular Diagnostics Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions